Prof. Arjan Griffioen, Founder and CSO of CimCure and Professor of Experimental Oncology at Amsterdam UMC, discusses CimCure’s cancer vaccine technology designed to target tumour blood vessels.
Looking for support?
How can we help you on your innovation journey? Contact our experts today.
